SER SERINA THERAPEUTICS INC Investor Conferences 8-K Filing 2025 - Investor Presentation On March 24, 2025, Serina Therapeutics announced that its Chief Development Officer, Randall Moreadith, will present at the American Chemistry Society Spring 2025 Meeting in San Diego, using materials included in the filing.Get access to all SEC 8-K filings of the SERINA THERAPEUTICS INC